| Long name: |
NCR2 Primary Polyclonal Antibody |
| Also known as: |
NCR2 PAb |
| Category: |
Primary Antibodies |
| Conjugation: |
Unconjugated |
| Target Antigen: |
NCR2 |
| Specificity: |
This is a highly specific antibody against NCR2 |
| Modification(s): |
None |
| Modification site(s): |
Unmodified antibody |
| Clonality: |
Polyclonal antibody |
| Clone number: |
Polyclonal antibody |
| Concentration: |
1ug per 1ul |
| Immunogen range: |
215-265/276 |
| Subcellular location: |
Cytoplasm |
| Source: |
This antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human CD336/NCR2 |
| Gene ID number: |
9436 |
| Swiss Prot: |
O95944 |
| Tested Applications: |
IF(IHC-P), IHC-P |
| Recommended dilutions: |
IF(IHC-P)(1:50-200), IHC-P(1:100-500) |
| Cross reactivity: |
Human |
| Cross reactive species details: |
not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Background of the target antigen: |
Cytotoxicity-activating receptor that may contribute to the increased efficiency of activated natural killer (NK) cells to mediate tumor cell lysis |
| Purification method: |
This antibody was purified via Protein A |
| Storage conditions: |
50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA |
| Synonym names: |
CD336, Lymphocyte antigen 95 homolog, NCR2, NK cell-activating receptor, NK-p44, NKP44, Natural cytotoxicity triggering receptor 2, Natural killer cell p44-related protein, dJ149M18, 1, LY95 |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24° |
| Gene target: |
NCR2 |
| Short name: |
NCR2 Antibody |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Alternative name: |
natural cytotoxicity triggering receptor 2 (Antibody to) |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
CD336 and dJ149M18, NCR2 and IDBG-86656 and ENSG00000096264 and 9436, Plasma membranes, protein binding, this GO :0004888 and transmembrane signaling receptor activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005886 and plasma membrane and cellular component this GO :0005887 and integral component of plasma membrane and cellular component this GO :0006968 and cellular defense response and biological process this GO :0007165 and signal transduction and biological process this GO :0045087 and innate immune response and biological process, this GO :0004888 : transmembrane signaling receptor activity, this GO :0004888 : transmembrane signaling receptor activity and also this GO :0005515 : protein binding, this GO :0005515 : protein binding, 1 and LY95 and NK-p44 and NKP44, natural cytotoxicity triggering receptor 2 |
| Identity: |
6732 |
| Gene: |
NCR2 |
More about : NCR2 |
| Long gene name: |
natural cytotoxicity triggering receptor 2 |
| Synonyms gene: |
LY95 |
| Synonyms gene name: |
NK-p44) , lymphocyte antigen 95 (activating NK-receptor |
| Synonyms: |
NK-p44 CD336 |
| Locus: |
6p21, 1 |
| Discovery year: |
1999-04-09 |
| GenBank acession: |
AJ225109 |
| Entrez gene record: |
9436 |
| Pubmed identfication: |
10049942 |
| Classification: |
CD molecules V-set domain containing |
| Havana BLAST/BLAT: |
OTTHUMG00000014678 |